Twin Tree Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Hold
0
753
2025
Q1
Hold
0
800
2024
Q4
Sell
-28,105
Closed -$3.24M 763
2024
Q3
$3.24M Buy
+28,105
New +$3.24M 0.01% 260
2024
Q2
Sell
-19,147
Closed -$2.64M 719
2024
Q1
$2.64M Sell
19,147
-17,764
-48% -$2.45M 0.01% 249
2023
Q4
$4.86M Buy
36,911
+12,712
+53% +$1.67M 0.01% 252
2023
Q3
$2.72M Buy
24,199
+19,022
+367% +$2.14M 0.01% 220
2023
Q2
$488K Buy
+5,177
New +$488K ﹤0.01% 375
2022
Q4
Sell
-12,477
Closed -$1.33M 625
2022
Q3
$1.33M Buy
12,477
+7,812
+167% +$830K ﹤0.01% 284
2022
Q2
$455K Sell
4,665
-7,182
-61% -$700K ﹤0.01% 467
2022
Q1
$1.11M Buy
11,847
+9,053
+324% +$849K ﹤0.01% 443
2021
Q4
$238K Sell
2,794
-11,800
-81% -$1.01M ﹤0.01% 485
2021
Q3
$1.4M Sell
14,594
-8,883
-38% -$852K ﹤0.01% 370
2021
Q2
$2.29M Buy
23,477
+17,310
+281% +$1.68M 0.01% 301
2021
Q1
$600K Buy
6,167
+4,397
+248% +$428K ﹤0.01% 363
2020
Q4
$170K Sell
1,770
-5,880
-77% -$565K ﹤0.01% 395
2020
Q3
$736K Buy
7,650
+2,479
+48% +$239K ﹤0.01% 296
2020
Q2
$631K Buy
5,171
+5,121
+10,242% +$625K ﹤0.01% 359
2020
Q1
$4K Sell
50
-2,589
-98% -$207K ﹤0.01% 495
2019
Q4
$284K Buy
2,639
+122
+5% +$13.1K ﹤0.01% 340
2019
Q3
$227K Buy
+2,517
New +$227K ﹤0.01% 339
2019
Q2
Sell
-2,118
Closed -$187K 790
2019
Q1
$187K Sell
2,118
-1,219
-37% -$108K ﹤0.01% 401
2018
Q4
$238K Buy
+3,337
New +$238K ﹤0.01% 341
2018
Q3
Hold
0
600
2018
Q2
Hold
0
610